Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.
Zymvol Biomodeling has raised $3.1M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
Zymvol Biomodeling's investors include Faber, Elaia, EASME, ubermorgen Ventures, Avancsa.
Zymvol Biomodeling is headquartered in Barcelona, Spain.
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.
Zymvol Biomodeling is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zymvol Biomodeling — Funding & Investors." VCBacked, February 20, 2025, https://www.vcbacked.co/company/zymvol-biomodeling. Accessed September 15, 2026.
VCBacked. (2025). Zymvol Biomodeling — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/zymvol-biomodeling
{{cite web |title=Zymvol Biomodeling — Funding & Investors |url=https://www.vcbacked.co/company/zymvol-biomodeling |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated